Up-regulation of survivin in oral squamous cell carcinoma correlates with poor prognosis and chemoresistance

Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology and Endodontology

Volumn 110, Issue 4, 2010, Pages 484-491

  Liping, Su ^a   Ying, Wang ^a   Mingzhen, Xiao ^a   Yuan, Lin ^a   Lei, Yu ^b  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; APOPTOSIS REGULATORY PROTEIN; BIRC5 PROTEIN, HUMAN; CISPLATIN; FLUOROURACIL; MESSENGER RNA; MICROTUBULE ASSOCIATED PROTEIN; TUMOR MARKER;

ARTICLE; BIOSYNTHESIS; CANCER STAGING; CHI SQUARE DISTRIBUTION; DRUG RESISTANCE; FEMALE; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; GENETICS; HUMAN; KAPLAN MEIER METHOD; MALE; METABOLISM; MIDDLE AGED; MOUTH TUMOR; PATHOLOGY; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; RNA INTERFERENCE; SQUAMOUS CELL CARCINOMA; TUMOR CELL LINE; UPREGULATION;

ANTINEOPLASTIC AGENTS; APOPTOSIS REGULATORY PROTEINS; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; CHI-SQUARE DISTRIBUTION; CISPLATIN; DRUG RESISTANCE, NEOPLASM; FEMALE; FLUOROURACIL; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MICROTUBULE-ASSOCIATED PROTEINS; MIDDLE AGED; MOUTH NEOPLASMS; NEOPLASM STAGING; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RNA INTERFERENCE; RNA, MESSENGER; TRANSFECTION; TUMOR MARKERS, BIOLOGICAL; UP-REGULATION;

EID: 77957150699     PISSN: 10792104     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tripleo.2010.04.009     Document Type: Article

References (21)

1. A. Jemal, R. Siegel, E. Ward, Y. Hao, J. Xu, T. Murray, and M.J. Thun Cancer statistics, 2008 CA Cancer J Clin 58 2008 71 96
2. S. Silverman Demographics and occurrence of oral and pharyngeal cancers The outcomes, the trends, the challenge J Am Dent Assoc 132 2001 7S 11S
3. D.M. Cohan, S. Popat, S.E. Kaplan, N. Rigual, T. Loree, and W.L. Hicks Jr Oropharyngeal cancer: current understanding and management Curr Opin Otolaryngol Head Neck Surg 17 2009 88 94
4. G. Ambrosini, C. Adida, and D.C. Altieri A noble antiapoptotic gene, survivin, is expressed in cancer and lymphoma Nat. Med 3 1997 917 921
5. Q.L. Deveraux, and J.C. Reed IAP family proteins: suppressors of apoptosis Genes Dev 13 1999 239 252
6. M. Ikeguchi, Y. Hirooka, and N. Kaibara Quantitative analysis of apoptosis-related gene expression in hepatocellular carcinoma Cancer 95 2002 1938 1945 (Pubitemid 35222174)
7. M. Ikeguchi, and N. Kaibara Survivin messenger RNA expression is a good prognostic biomarker for esophageal carcinoma Br J Cancer 87 2002 883 887 (Pubitemid 35252964)
8. K. Tanaka, S. Iwamoto, G. Gon, T. Nohara, M. Iwamoto, and N. Tanigawa Expression of survivin and its relationship to loss of apoptosis in breast carcinomas Clin Cancer Res 6 2000 127 134
9. L. Mao, W.K. Hong, and V.A. Papadimitrakopoulou Focus on head and neck cancer Cancer Cell 5 2004 311 316
10. A.M. Hunter, E.C. LaCasse, and R.G. Korneluk The inhibitors of apoptosis (IAPs) as cancer targets Apoptosis 12 2007 1543 1568
11. D.C. Altieri Survivin, versatile modulation of cell division and apoptosis in cancer Oncogene 22 2003 8581 8589
12. H.S. Kim, K. Shiraki, and S.H. Park Expression of survivin in CIN and invasive squamous cell carcinoma of uterine cervix Anticancer Res 22 2002 805 808
13. L.J. Lin, C.Q. Zheng, Y. Jin, Y. Ma, W.G. Jiang, and T. Ma Expression of survivin protein in human colorectal carcinogenesis World J Gastroenterol 9 2003 974 977
14. P.N. Span, F.C. Sweep, and E.T. Wiegerinck Survivin is an independent prognostic marker for risk stratification of breast cancer patients Clin Chem 50 2004 1986 1993
15. A.I. Sarela, R.C. Macadam, S.M. Farmery, A.F. Markham, and P.J. Guillou Expression of the antiapoptosis gene, Survivin, predicts death from recurrent colorectal carcinoma Gut 46 2000 645 650
16. Y.M. Liu, J.H. Huang, D.Y. Feng, and X.C. Guo Expression of survivin and its correlation to angiogenesis in oral squamous cell carcinoma Ai Zheng 24 2005 1354 1357
17. G. Capalbo, C. Rdel, R.H. Stauber, S.K. Knauer, M. Bache, M. Kappler, and F. Rdel The role of survivin for radiation therapy Prognostic and predictive factor and therapeutic target Strahlenther Onkol 183 2007 593 599
18. K. Kami, R. Doi, M. Koizumi, E. Toyoda, T. Mori, and D. Ito Downregulation of survivin by siRNA diminishes radioresistance of pancreatic cancer cells Surgery 138 2005 299 305
19. J. Kato, Y. Kuwabara, M. Mitani, N. Shinoda, A. Sato, and T. Toyama Expression of survivin in esophageal cancer: correlation with the prognosis and response to chemotherapy Int J Cancer 95 2001 92 95
20. J. Shen, J. Liu, Y. Long, Y. Miao, M. Su, and Q. Zhang Knockdown of survivin expression by siRNAs enhances chemosensitivity of prostate cancer cells and attenuates its tumorigenicity Acta Biochim Biophys Sin (Shanghai) 41 2009 223 230
21. H. Song, X.Y. Xin, F. Xiao, D.T. Wang, Q.H. Yue, and X. Han Survivin gene RNA interference inhibits proliferation, induces apoptosis, and enhances radiosensitivity in HeLa cells Eur J Obstet Gynecol Reprod Biol 136 2008 83 89